Management of Snake Bite Full Background Document (Draft) January 2016

Management of Snake Bite Full Background Document (Draft) January 2016

STANDARD TREATMENT GUIDELINES Management of Snake Bite Full Background Document (Draft) January 2016 Ministry of Health & Family Welfare Government of India Management of Snakebite – Full Background Document Ver. 4.0 Contents Introduction ........................................................................................................................................... 4 The Need for the STG ........................................................................................................................ 4 The purpose of the STG ..................................................................................................................... 5 Declaration of Interest ....................................................................................................................... 5 The funding source ............................................................................................................................ 5 3. The Scheduled review .................................................................................................................... 5 4. Scope of the STG ............................................................................................................................ 5 5. List of all recommendations .............................................................. Error! Bookmark not defined. 6. Methodology ..................................................................................................................................... 6 How the relevant guideline(s) were selected as source of recommendation .................................. 7 How recommendations were selected, adopted or adapted ........................................................... 9 Recommendations ................................................................................................................................ 9 Stages of management (WHO) ............................................................................................................ 10 First Aid Treatment Guidelines (Bystanders/victim) ........................................................................... 11 Treatment in the dispensary or hospital ............................................................................................. 17 Signs and symptoms of snakebite .................................................................................................... 17 Asymptomatic Arrival (A2) ............................................................................................................... 18 Symptomatic Patients (A2) .............................................................................................................. 19 CRITICAL ARRIVAL ............................................................................................................................ 24 Non critical arrival and critical arrival after stabilization .................. Error! Bookmark not defined. Diagnosis: Signs and Symptoms of Envenoming .............................. Error! Bookmark not defined. ANTI SNAKE VENOM (ASV) .................................................................................................................. 32 ASV dosage forms ............................................................................................................................... 34 What Can ASV Do and more importantly what can it NOT Do? (A2) .............................................. 34 Swelling and ASV .............................................................................................................................. 38 ASV Safety ........................................................................................................................................ 38 ASV Administration Criteria .............................................................. Error! Bookmark not defined. Inappropriate use of antivenom (WHO) .......................................................................................... 32 How long after the bite can antivenom be expected to be effective? ............................................ 38 How to administer ASV ..................................................................... Error! Bookmark not defined. ASV Dosage ...................................................................................................................................... 35 Initial Dosing Exceptions (A2) .......................................................................................................... 36 Late Administration of ASV ............................................................... Error! Bookmark not defined. ASV and Pregnancy .......................................................................................................................... 39 Paediatric ASV Dosing ...................................................................................................................... 40 Repeat Bites ..................................................................................................................................... 40 Adverse Anti Snake Venom Reactions ................................................................................................. 41 Mechanism of the Reaction ............................................................................................................. 42 Prediction of Adverse Reactions ...................................................................................................... 42 Preventing Adverse Reactions ......................................................................................................... 42 Treatment of Adverse Reactions ..................................................................................................... 43 Contraindications to antivenom: Prophylaxis of high risk patients (WHO) ......................................... 45 Observation of the response to antivenom ......................................................................................... 45 Haemotoxic Envenomation, Blood Products and Renal Impairment .................................................. 52 Hypotension ...................................................................................... Error! Bookmark not defined. Persistent or Severe bleeding .......................................................................................................... 53 Management of Snakebite – Full Background Document Ver. 4.0 Role of Anticoagulants ..................................................................................................................... 54 Renal Failure and ASV .......................................................................................................................... 55 Pain, Wound Management and the Surgical Aspects of Snakebite .................................................... 58 Snake Venom Ophthalmia ................................................................................................................... 59 Surgery and Snakebite ......................................................................................................................... 60 Snakebite & Life Threatening Conditions Requiring Surgery .......................................................... 60 Debridement of Necrotic Tissue ...................................................................................................... 60 Compartment Syndrome ................................................................................................................. 61 Conservative treatment when no antivenom is available ................................................................... 63 Follow-up ............................................................................................................................................. 64 Rehabilitation ....................................................................................................................................... 64 Snakebite Management in Basic or Primary Care Facilities ................................................................ 65 At the community or village level (WHO) ............................................................................................ 65 At the rural clinic, dispensary or health post ........................................ Error! Bookmark not defined. At the district hospital .......................................................................... Error! Bookmark not defined. D. At the referral (specialized) hospital ................................................ Error! Bookmark not defined. Conditions and Equipment Accompanying Neurotoxic Referral ......................................................... 65 Equipping a Basic Hospital for Effective Snakebite Management (A2) ............................................... 71 Holding Quantities of ASV/ Stocks of ASV........................................................................................ 71 Snakebite Prevention & Occupational Risk ......................................................................................... 72 Management of Snakebite – Full Background Document Ver. 4.0 Introduction The Need for the STG Snakebite is an acute life threatening time limiting medical emergency. It is a preventable public health hazard often faced by rural population in tropical and subtropical countries with heavy rainfall and humid climate. There is a huge gap between the number of snakebite deaths reported from direct survey and official data. Only 7.23% snakebite deaths

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    87 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us